The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials?

被引：12

作者：

Feldman, AM

Kadokami, T

Higuichi, Y

Ramani, R

McTiernan, CF

机构：

[1] Thomas Jefferson Univ, Coll Med, Dept Med, Philadelphia, PA 19107 USA

[2] Univ Pittsburgh, Ctr Med, Pittsburgh, PA USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2003年 / 87卷 / 02期

关键词：

D O I：

10.1016/S0025-7125(02)00189-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A decade ago, investigators first recognized that levels of the proinflammatory cytokine, tumor necrosis factor-alpha (TNFalpha), were elevated in patients with heart failure. Subsequent studies in isolated myocytes and in mice that overexpress TNF demonstrated that TNF could recapitulate the cellular biology and biochemistry of the failing human heart. In addition, anticytokine strategy in experimental models effected dramatic changes in the heart failure phenotype. The initial enthusiasm that was engendered by the studies in animal models has been tempered by a failure of these agents in phase II and III trials. The reassessment of basic and clinical science data regarding TNF pathobiology provides insight about these recent disparate results. To better understand this conundrum, this article reviews the basic pathobiology of TNF, the effects of anticytokine therapy in experimental and clinical studies, and an assessment of the future role of anticytokine therapy in the management of heart failure.

引用

页码：419 / +

页数：23

共 107 条

[1] Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease [J].

Bachmaier, K ;

Pummerer, C ;

Kozieradzki, I ;

Pfeffer, K ;

Mak, TW ;

Neu, N ;

Penninger, JM .

CIRCULATION, 1997, 95 (03) :655-661

[2]

Bergman MR, 1997, J PHARMACOL EXP THER, V280, P520

[3]

Bergman MR, 1996, J PHARMACOL EXP THER, V279, P247

[4] UNRAVELING FUNCTION IN THE TNF LIGAND AND RECEPTOR FAMILIES [J].

BEUTLER, B ;

VANHUFFEL, C .

SCIENCE, 1994, 264 (5159) :667-668

[5]

Birks EJ, 2000, CIRCULATION, V102, P352

[6] A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].

Black, RA ;

Rauch, CT ;

Kozlosky, CJ ;

Peschon, JJ ;

Slack, JL ;

Wolfson, MF ;

Castner, BJ ;

Stocking, KL ;

Reddy, P ;

Srinivasan, S ;

Nelson, N ;

Boiani, N ;

Schooley, KA ;

Gerhart, M ;

Davis, R ;

Fitzner, JN ;

Johnson, RS ;

Paxton, RJ ;

March, CJ ;

Cerretti, DP .

NATURE, 1997, 385 (6618) :729-733

[7]

Bounoutas GS, 1998, CIRCULATION, V98, P737

[8] Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats [J].

Bozkurt, B ;

Kribbs, SB ;

Clubb, FJ ;

Michael, LH ;

Didenko, VV ;

Hornsby, PJ ;

Seta, Y ;

Oral, H ;

Spinale, FG ;

Mann, DL .

CIRCULATION, 1998, 97 (14) :1382-1391

[9]

Bozkurt Biykem, 1999, Journal of the American College of Cardiology, V33, p184A

[10] CYTOPLASMIC TRUNCATION OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR ABOLISHES SIGNALING, BUT NOT INDUCED SHEDDING OF THE RECEPTOR [J].

BRAKEBUSCH, C ;

NOPHAR, Y ;

KEMPER, O ;

ENGELMANN, H ;

WALLACH, D .

EMBO JOURNAL, 1992, 11 (03) :943-950

← 1 2 3 4 5 6 7 8 9 10 →